192(top 27%)
articles
2.8K(top 26%)
citations
29(top 26%)
★★ articles
1(top 20%)
★★★ articles
2(top 32%)
Avg IF
28(top 25%)
H-Index
50(top 24%)
G-Index
137
journals

Most Cited Articles of Banner Health in 2016

TitleJournalYearCitations
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS - 2016Endocrine Practice2016314
Effectiveness of Practices To Increase Timeliness of Providing Targeted Therapy for Inpatients with Bloodstream Infections: a Laboratory Medicine Best Practices Systematic Review and Meta-analysisClinical Microbiology Reviews2016160
Proposed diagnostic criteria for the case definition of amniotic fluid embolism in research studiesAmerican Journal of Obstetrics and Gynecology201691
Multicenter analysis comparing robotic, open, laparoscopic, and vaginal hysterectomies performed by high-volume surgeons for benign indicationsInternational Journal of Gynecology and Obstetrics201657
Own the Bone, a System-Based Intervention, Improves Osteoporosis Care After Fragility FracturesJournal of Bone and Joint Surgery - Series A201644
A Patient Blood Management Program in Prosthetic Joint Arthroplasty Decreases Blood Use and Improves OutcomesJournal of Arthroplasty201637
ICU Telemedicine Comanagement Methods and Length of StayChest201636
Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study GroupPLoS ONE201631
KlebSeq, a Diagnostic Tool for Surveillance, Detection, and Monitoring of Klebsiella pneumoniaeJournal of Clinical Microbiology201626
Drug Class Combination-Associated Acute Kidney InjuryAnnals of Pharmacotherapy201623
Evidence for Implementation Strategies to Provide Palliative Care in the Neonatal Intensive Care UnitAdvances in Neonatal Care201617
Reproducibility and Bias in Healthy Brain Segmentation: Comparison of Two Popular Neuroimaging PlatformsFrontiers in Neuroscience201617
Real-Time Automated Sampling of Electronic Medical Records Predicts Hospital MortalityAmerican Journal of Medicine201617
Is the robotic approach feasible for repair of iatrogenic injuries of the lower ureter?World Journal of Urology201611
Effect of the Suboccipital Musculature on Symptom Severity and Recovery after Mild Traumatic Brain InjuryAmerican Journal of Neuroradiology201611
Health Care Transformation: A Strategy Rooted in Data and AnalyticsAcademic Medicine201610
Dietary high cholesterol and trace metals in the drinking water increase levels of ABCA1 in the rabbit hippocampus and temporal cortexJournal of Alzheimer's Disease20165
Intrapartum sonographic signs: new diagnostic tools in malposition and malrotationJournal of Maternal-Fetal and Neonatal Medicine20165
Nurses' Professional Caring Presence and the Power to Affect ChangeNursing for Women's Health20163
Updated overall survival analysis of NAPOLI-1: Phase III study of nanoliposomal irinotecan (nal-IRI, MM-398), with or without 5-fluorouracil and leucovorin (5-FU/LV), versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy.Journal of Clinical Oncology20163
Distinct differences in striatal dysmorphology between attention deficit hyperactivity disorder boys with and without a comorbid reading disabilityPsychiatry Research - Neuroimaging20162
Virtual Worlds in HealthcareAnnals of Information Systems20162
Transperineal ultrasoundChoonpa Igaku20161
Effect of baseline carbohydrate antigen 19-9 (CA19-9) level on overall survival (OS) in NAPOLI-1 trial: A phase III study of MM-398 (nal-IRI), with or without 5-fluorouracil and leucovorin (5-FU/LV), versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy.Journal of Clinical Oncology20161
Effect of baseline carbohydrate antigen 19-9 (CA19-9) level on overall survival (OS) in NAPOLI-1: A randomized phase III study of MM-398 (nal-IRI), with or without 5-fluorouracil and leucovorin (5-FU/LV), versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine (gem)-based therapy.Journal of Clinical Oncology2016